SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-039784
Filing Date
2023-08-08
Accepted
2023-08-08 16:07:33
Documents
69
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ubx-20230630.htm   iXBRL 10-Q 3083661
2 EX-31.1 ubx-ex31_1.htm EX-31.1 21334
3 EX-31.2 ubx-ex31_2.htm EX-31.2 21281
4 EX-32.1 ubx-ex32_1.htm EX-32.1 21149
  Complete submission text file 0000950170-23-039784.txt   10723937

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ubx-20230630_lab.xml EX-101.LAB 511918
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ubx-20230630_cal.xml EX-101.CAL 54275
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ubx-20230630_pre.xml EX-101.PRE 372689
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ubx-20230630.xsd EX-101.SCH 69873
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ubx-20230630_def.xml EX-101.DEF 234941
63 EXTRACTED XBRL INSTANCE DOCUMENT ubx-20230630_htm.xml XML 2039974
Mailing Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-1192
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38470 | Film No.: 231151269
SIC: 2834 Pharmaceutical Preparations